In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.

Strigl, S; Roblin, P M; Reznik, T; Hammerschlag, M R

Name:

aac.44.4.1112-1113.2000.pdf

Size:

34.96Kb

Format:

PDF

Download

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Author

Strigl, S
Roblin, P M
Reznik, T
Hammerschlag, M R

Journal title

Antimicrobial agents and chemotherapy

Date Published

2000-04

Publication Volume

Publication Issue

Publication Begin page

1112

Publication End page

Metadata

Show full item record

URI

http://hdl.handle.net/20.500.12648/10351

Abstract

The in vitro activities of ABT 773, telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin, and levofloxacin were tested against 20 strains of Chlamydia pneumoniae. The MIC at which 90% of the isolates were inhibited and the minimal bactericidal concentration at which 90% of the isolates were killed by ABT 773 were 0.015 microg/ml (range, 0.008 to 0.015 microg/ml). ABT 773 was the most active antibiotic tested in this study.

Citation

Strigl S, Roblin PM, Reznik T, Hammerschlag MR. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrob Agents Chemother. 2000 Apr;44(4):1112-3. doi: 10.1128/AAC.44.4.1112-1113.2000. PMID: 10722526; PMCID: PMC89827.

Collections

Downstate College of Medicine

The following license files are associated with this item:

Creative Commons

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International